Effect of insulin on apolipoprotein(a) synthesis
Dear Sir, Neele et al. have reported that apolipoprotein(a) and apolipoprotein B-100 secretion by cynomolgus monkey hepatocytes is modestly inhibited after incubation with insulin in concentrations ranging from 10 4 to 10 6 pmol/l [1] . Such insulin concentrations are approximately 15 to 1500-fold higher than those measured after a glucose challenge in humans. Nonetheless, they state that an insulin concentration of 10 4 pmol/l is low and relevant, considering a half life of insulin about 4 h under the experimental conditions used. They do not, however, show that this assumption is correct. In comparison, others have shown effects on cholesterol uptake by HepG2 cells and rat hepatocytes when insulin is added in a concentration as low as 600 pmol/l [2] . Furthermore, they use an enzyme linked immunoassay that measures the apo(a) moiety of lipoprotein(a) [3] and not free apo(a). Since it is most likely that the assembly of lipoprotein(a) is an extracellular event [4] , it is possible that the observed decrease in so-called apo(a) is confounded by a decrease in apolipoprotein B-100. Finally, there is no evidence that insulin decreases plasma lipoprotein(a) in healthy humans, despite the lowering of apolipoprotein B-100 synthesis [5] . For these reasons, it is our opinion that the findings of the in vitro study by Neele et al. cannot be extrapolated to the in vivo situation in humans.
Yours sincerely, S. C. Riemens, R. P. F. Dullaart
Insulin suppresses apolipoprotein(a) synthesis in cultured cynomolgus monkey hepatocytes Dear Sir, In their comment on our paper which appeared in Diabetologia 42: 41±44 Riemens and Dullaart conclude that the findings of our in vitro study cannot be extrapolated to the in vivo situation in humans. We fully agree with this statement and have not attempted to make such an extrapolation in our paper. We just suggested that our findings that insulin suppresses apolipoprotein(a) synthesis in primary cultures of cynomolgus monkey hepatocytes could provide an explanation for the increased plasma concentrations of lipoprotein(a) found in patients with insulin dependent diabetes mellitus and its return to normal after treatment with insulin (as stated clearly in the Summary and in the Discussion). The next step is to prove this in turn-over studies in appropriate experimental animals and in humans.
In studies of the metabolic effects of insulin in cell culture experiments, using hepatocytes from different species, the insulin concentrations applied are usually in the range of 1 to 150 nmol/l. In this context the concentration at which we found statistically significant effects (10 nmol/l) (p < 0.05) was considered to be low. It is well-known that hepatocytes degrade insulin [1, 2] . As far as we know, no data are available on the half-life of insulin in primary cultures of monkey hepatocytes. If we assume, however, that the insulin half-life in the latter hepatocyte cultures is similar to that in rat hepatocytes [3] and HepG2 cells [4] , which is between 4 and 5 h in both cell models, 10 nmol/l is a relevant concentration. After 24 h of culture (the length of our incubation periods) about 2 % of the initial concentrations are left, being approximately 0.2 nmol/l. To be able to measure sufficient amounts of apolipoprotein(a) accumulating in the medium, we need to do overnight incubations. We choose incubation periods of 24 h, explaining the necessity for high initial concentrations compared with insulin concentrations in humans. We have reported previously that extinction of initially activated gene expression may occur during 24-h incubation periods without intermediate renewing of biologically active compounds which are heavily metabolised by hepatocytes [5] . As we have shown the suppressing effect of insulin (10 nmol/l) on apolipoprotein(a) expression was statistically significant (p < 0.05) after two 24-h periods, indicating that regulation is relatively slow. If on the other hand, metabolic effects of insulin proceed rapidly, i. e. within a few hours, lower initial insulin concentrations can be applied. This is the case in a report that the effect of insulin (0.6 nmol/l) on cholesterol removal from macrophages reaches a maximum after 4 to 6 h [6] . Similarly, e. g. mRNA expression of microsomal triglyceride transfer protein in HepG2 cells decreased within 4 to 6 h at 1 nmol/l insulin [7] and we found that 1.4 nmol/l insulin increased plasminogen activator inhibitor-1 activity and mRNA expression after 4 h in HepG2 cells and human hepatocytes [8] . In conclusion, results at high initial insulin concentrations are perhaps more physiologically relevant than thought and may reflect insulin effects as occur during peak portal concentrations (approximately 0.5 nmol/l).
The enzyme-linked immunoassay in our experiments (TintElize, Biopool AB) uses polyclonal antibodies to human apolipoprotein(a) both as catching and detecting antibodies. The assay measures both free apolipoprotein(a) and apolipoprotein(a) contained in the lipoprotein(a) particle with equal affinity, i. e. the assay measures total apolipoprotein(a). So, there is no reason to think that the apolipoprotein(a) measurements are confounded by a decrease in apolipoprotein B100. In addition, we also found down regulation of apolipoprotein(a) mRNA expression, indicating regulation at the (post-) transcriptional expression.
Riemens and Dullaart refer to a paper by Malmström et al., who report that the VLDL1 apoB synthesis in humans is decreased by 51 % during a period of 8.5 h of hyperinsulinaemia [9] . In that paper the synthesis of apolipoprotein(a) was not measured and to our knowledge this has not been done yet during hyperinsulinaemia. Because of the half-life of lipoprotein(a), being 2 to 3 days [10] , it is not possible to observe statistically significant changes in plasma lipoprotein(a) concentrations during such a short period.
Yours sincerely, H. M. G. Princen
Inefficient analysis of twin data: is there an association between diabetes and birth weight?
Dear Sir, Poulsen et al. [1] examine if there exists a relation between birth weight and Type II (non-insulin-dependent) diabetes mellitus, not due to factors such as maternal height, gestational age and sex. To be able to control these factors the study was based on twin pairs of the same sex. Unfortunately, the authors did not analyse their data with the most powerful statistical methods and due to this, possible important associations may have been missed. In one of the analyses the twins were divided into two groups, one group (A) containing twins with the heavier birth weight from each pair and one group (B) containing twins with the lighter birth weight (Table 2 p. 443). For each independent variable, X i , The Wilcoxon signed rank test for paired data was calculated. A significant result indicates an association between birth weight and variable X i A more powerful method than the pairwise test described above is to use the correlation between intra-pair differences.
